Bernard Masereel

6.1k total citations
136 papers, 5.2k citations indexed

About

Bernard Masereel is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Bernard Masereel has authored 136 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Organic Chemistry, 67 papers in Molecular Biology and 28 papers in Pharmacology. Recurrent topics in Bernard Masereel's work include Synthesis and Catalytic Reactions (19 papers), Enzyme function and inhibition (18 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (16 papers). Bernard Masereel is often cited by papers focused on Synthesis and Catalytic Reactions (19 papers), Enzyme function and inhibition (18 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (16 papers). Bernard Masereel collaborates with scholars based in Belgium, Italy and France. Bernard Masereel's co-authors include Claudiu T. Supuran, Anne Thiry, Lionel Pochet, Jean‐Michel Dogné, Johan Wouters, Raphaël Frédérick, Jean-Michel Dogné, Andrea Scozzafava, Stéphanie Rolin and Bernard Pirotte and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Materials Chemistry and Journal of Colloid and Interface Science.

In The Last Decade

Bernard Masereel

134 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Masereel Belgium 38 2.7k 2.1k 896 481 425 136 5.2k
Gregory R. J. Thatcher United States 38 2.1k 0.8× 1.4k 0.7× 408 0.5× 87 0.2× 136 0.3× 195 5.1k
Kenneth L. Kirk United States 39 2.3k 0.8× 3.2k 1.5× 291 0.3× 90 0.2× 112 0.3× 183 7.8k
Yingjun Zhao China 34 1.1k 0.4× 495 0.2× 364 0.4× 266 0.6× 190 0.4× 103 4.6k
Toshimasa Toyo’oka Japan 47 3.0k 1.1× 460 0.2× 364 0.4× 265 0.6× 87 0.2× 255 7.1k
Naoki Miyata Japan 55 3.6k 1.3× 3.0k 1.4× 312 0.3× 117 0.2× 251 0.6× 234 8.9k
Federico Da Settimo Italy 42 2.4k 0.9× 1.9k 0.9× 415 0.5× 111 0.2× 59 0.1× 210 5.3k
Bruce E. Maryanoff United States 52 3.5k 1.3× 6.8k 3.2× 903 1.0× 38 0.1× 165 0.4× 265 11.7k
Hans Nohl Austria 47 3.6k 1.3× 787 0.4× 192 0.2× 120 0.2× 114 0.3× 148 7.3k
Pier Giovanni Baraldi Italy 58 4.9k 1.8× 5.8k 2.7× 865 1.0× 49 0.1× 61 0.1× 319 11.1k
Zhangjian Huang China 34 1.5k 0.6× 1.0k 0.5× 476 0.5× 69 0.1× 43 0.1× 134 4.1k

Countries citing papers authored by Bernard Masereel

Since Specialization
Citations

This map shows the geographic impact of Bernard Masereel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Masereel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Masereel more than expected).

Fields of papers citing papers by Bernard Masereel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Masereel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Masereel. The network helps show where Bernard Masereel may publish in the future.

Co-authorship network of co-authors of Bernard Masereel

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Masereel. A scholar is included among the top collaborators of Bernard Masereel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Masereel. Bernard Masereel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chu, Jennifer, Róbert Kiss, Guy Vandenbussche, et al.. (2017). A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis. European Journal of Pharmacology. 805. 25–35. 52 indexed citations
2.
Masereel, Bernard, et al.. (2015). Preparation and characterization of a new harmine-based antiproliferative compound in complex with cyclodextrin: Increasing solubility while maintaining biological activity. European Journal of Pharmaceutical Sciences. 77. 135–140. 11 indexed citations
3.
Meignan, Samuel, Catherine Foulon, Perrine Six, et al.. (2012). New selective carbonic anhydrase IX inhibitors: Synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides. Bioorganic & Medicinal Chemistry. 21(6). 1451–1464. 59 indexed citations
4.
Joseph, Pascale, Jérémie Mortier, Jean‐Louis Montero, et al.. (2011). Anti-virulence Strategy against Brucella suis: Synthesis, Biological Evaluation and Molecular Modeling of Selective Histidinol Dehydrogenase Inhibitors. Organic & Biomolecular Chemistry. 9(10). 3681–3681. 17 indexed citations
5.
Dubois, Ludwig J., Sarah G.J.A. Peeters, Natasja G. Lieuwes, et al.. (2011). Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. Radiotherapy and Oncology. 99(3). 424–431. 132 indexed citations
6.
Piret, Jean‐Pascal, Sébastien Vankoningsloo, Jorge Mejia, et al.. (2011). Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape. Nanotoxicology. 6(7). 789–803. 54 indexed citations
7.
Frédérick, Raphaël, et al.. (2010). Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors. Bioorganic & Medicinal Chemistry. 19(1). 134–144. 4 indexed citations
8.
Masereel, Bernard, Anne Thiry, Jean-Michel Dogné, & Claudiu T. Supuran. (2008). Anticonvulsant Sulfonamides/Sulfamates/Sulfamides with Carbonic Anhydrase Inhibitory Activity: Drug Design and Mechanism of Action. Current Pharmaceutical Design. 14(7). 661–671. 118 indexed citations
9.
Thiry, Anne, Laurence Goossens, Raymond Houssin, et al.. (2008). Synthesis and biological evaluation of a new family of anti-benzylanilinosulfonamides as CA IX inhibitors. European Journal of Medicinal Chemistry. 44(2). 511–518. 12 indexed citations
10.
Thiry, Anne, Bernard Masereel, Jean‐Michel Dogné, et al.. (2007). Exploration of the Binding Mode of Indanesulfonamides as Selective Inhibitors of Human Carbonic Anhydrase Type VII by Targeting Lys 91. ChemMedChem. 2(9). 1273–1280. 22 indexed citations
11.
D’Ambrosio, Katia, Bernard Masereel, Anne Thiry, et al.. (2007). Carbonic Anhydrase Inhibitors: Binding of Indanesulfonamides to the Human Isoform II. ChemMedChem. 3(3). 473–477. 10 indexed citations
12.
Thiry, Anne, Jean‐Michel Dogné, Bernard Masereel, & Claudiu T. Supuran. (2006). Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Trends in Pharmacological Sciences. 27(11). 566–573. 345 indexed citations
13.
Kolh, Philippe, Stéphanie Rolin, Vincent Tchana‐Sato, et al.. (2005). Evaluation of BM-573, a novel TXA2 synthase inhibitor and receptor antagonist, in a porcine model of myocardial ischemia-reperfusion. Prostaglandins & Other Lipid Mediators. 79(1-2). 53–73. 4 indexed citations
14.
Michaux, Catherine, Stéphanie Rolin, Xavier de Leval, et al.. (2005). Synthesis, molecular modelling and enzymatic evaluation of (±)3,5-diphenyl-2-thioxoimidazolidin-4-ones as new potential cyclooxygenase inhibitors. Bioorganic & Medicinal Chemistry. 14(4). 918–927. 16 indexed citations
15.
Dogné, Jean‐Michel, Xavier de Leval, Julien Hanson, et al.. (2004). New Developments on Thromboxane and Prostacyclin Modulators Part I: Thromboxane Modulators. Current Medicinal Chemistry. 11(10). 1223–1241. 68 indexed citations
16.
Rolin, Stéphanie, et al.. (2004). Pharmacological evaluation of both enantiomers of (R,S)-BM-591 as thromboxane A2 receptor antagonists and thromboxane synthase inhibitors. Prostaglandins & Other Lipid Mediators. 74(1-4). 75–86. 1 indexed citations
17.
Lambermont, Bernard, P. Kolh, Vincent Tchana‐Sato, et al.. (2003). Effects of endotoxic shock on right ventricular systolic function and mechanical efficiency. Cardiovascular Research. 59(2). 412–418. 44 indexed citations
18.
Rolin, Stéphanie, Jean‐Michel Dogné, Catherine Michaux, J. Delarge, & Bernard Masereel. (2001). Activity of a novel dual thromboxane A2receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles. Prostaglandins Leukotrienes and Essential Fatty Acids. 65(2). 67–72. 29 indexed citations
19.
Leval, Xavier de, J. Delarge, P. Neven, et al.. (2001). Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood. Prostaglandins Leukotrienes and Essential Fatty Acids. 64(4-5). 211–216. 23 indexed citations
20.
Golstein, Philippe, et al.. (1999). P-glycoprotein inhibition by glibenclamide and related compounds. Pflügers Archiv - European Journal of Physiology. 437(5). 652–660. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026